Ahmed et al. investigated how CRC cells resist radiotherapy through the expression of FGFR4 and observed that inhibition of FGFR4 can attenuate RAD51-mediated DSB repair, thereby attenuating the anti-radiation effect [41]. This evidence concerns the gene FGFR4 and colorectal carcinoma.